Max Chat
Calendrier des promotions DarioHealth Corp.
Calendrier avancé
Graphique simple
À propos de l'entreprise DarioHealth Corp.
DarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia, and New Zealand. The company offers Dario Evolve, a metabolic solution to address metabolic health needs, such as diabetes, hypertension, and weight management; Dario Move, which helps to prevent and treat the most common MSK conditions; Dario Elevate, a behavioral health solution that optimizes access to evidence-based care; Dario One, a full suite of chronic condition management solutions; DarioEngage platform; and Dario blood glucose monitoring system. It also provides smart glucose meters; bluetooth connected blood pressure cuff; digital scales; biofeedback sensor devices; and Dario smart diabetes management solutions, including live clinical coaching, content, automated journeys, hardware, and lifestyle coaching. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.Paramètres de base
IPO date
2014-10-06
ISIN
US23725P2092
Industry
Health Care Equipment & Supplies
Sector
Health Care
Валюта
usd
Валюта отчета
usd
Сайт
Grade
Sous-estimation
| Nom | Signification | Grade |
| P/S | 1.95 | 7 |
| P/BV | 0.7331 | 10 |
| P/E | 1.29 | 10 |
Efficacité
| Nom | Signification | Grade |
| ROA | 38.07 | 9 |
| ROE | 62.97 | 10 |
| ROIC | 0 | 0 |
Dividendes
| Nom | Signification | Grade |
| Rendement en dividendes | 0 | 0 |
| DSI | 0 | 0 |
| Croissance moyenne du dividende | 0 | 0 |
Devoir
| Nom | Signification | Grade |
| Debt/EBITDA | -0.5229 | 10 |
| Debt/Ratio | 0.254 | 10 |
| Debt/Equity | 0.6507 | 9 |
Impulsion de croissance
| Nom | Signification | Grade |
| Rentabilité Revenue, % | 255.79 | 10 |
| Rentabilité Ebitda, % | 91.21 | 9 |
| Rentabilité EPS, % | -112.55 | 0 |
paper.price.prices
| Prix | Common.min. | Common.max. | Changement | paper.changes_in_industry | paper.changes_in_index | |
| common.calendar.number_days.1 | 0.666 $ | 0 $ | 0 $ | 0 % | 0 % | 0 % |
| common.calendar.number_days.7d | 0.72 $ | 0 $ | 0 $ | -7.5 % | 0 % | 0 % |
| common.calendar.number_days.30d | 0.7196 $ | 0.666 $ | 0.72 $ | -7.45 % | 0 % | 0 % |
| common.calendar.number_days.90d | 0.7256 $ | 0.556 $ | 0.82 $ | -8.21 % | 0 % | 0 % |
| common.calendar.number_days.180d | 0.6886 $ | 0.556 $ | 0.92 $ | -3.28 % | 0 % | 0 % |
| common.calendar.number_days.1y | 0.82 $ | 0.556 $ | 1.53 $ | -18.78 % | 0 % | 0 % |
| common.calendar.number_days.3y | 4.76 $ | 0.556 $ | 7.16 $ | -86.01 % | 0 % | 0 % |
| common.calendar.number_days.5y | 13.84 $ | 0.556 $ | 30.42 $ | -95.19 % | 0 % | 0 % |
| common.calendar.number_days.10y | 0.2037 $ | 0.2037 $ | 30.42 $ | 326.95 % | 0 % | 0 % |
| common.calendar.number_days.ytd | 0.63 $ | 0.556 $ | 1.53 $ | 5.71 % | 0 % | 0 % |
Principaux propriétaires
Entreprises similaires
P/E & P/BV
Gestion d'entreprise
| Superviseur | Titre d'emploi | Paiement | Année de naissance |
| Mr. Erez Raphael | CEO & Director | 722.19k | 1973 (52 année) |
| Dov Oppenheim | Co-Founder & Production Chief | N/A | |
| Josh Fischer | Senior Vice President of Operations & Compliance | N/A | |
| Claudia Levi | Content & Communications Manager | N/A | |
| Mr. Jean Christophe Muyl | Head of Commercialization North America | N/A | |
| Mr. Tomer Ben-Kiki | Chief Technology Officer | N/A | 1971 (54 année) |
| Limor Drezner | Chief People Officer | N/A | |
| Mr. Zvi Ben David CPA | CFO, Treasurer & Secretary | 342.58k | 1961 (64 année) |
| Kat Parrella | Investor Relations Manager | ||
| Ms. Mona Dean | Chief Compliance Officer |
Informations sur l'entreprise
Adresse: United States, New York. NY, 18 West 18th Street - Ouvrir dans google maps, Ouvrir les cartes yandex
Site web: https://www.dariohealth.com
Site web: https://www.dariohealth.com
